Business Description
Filament Health Corp
NAICS : 325412
SIC : 3741
ISIN : CA31685W1068
Description
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.57 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -10.33 | |||||
| Beneish M-Score | 1.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 33.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.63 | |||||
| 9-Day RSI | 50.62 | |||||
| 14-Day RSI | 50.08 | |||||
| 6-1 Month Momentum % | -72.22 | |||||
| 12-1 Month Momentum % | -37.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.28 | |||||
| Quick Ratio | 1.28 | |||||
| Cash Ratio | 0.68 | |||||
| Days Sales Outstanding | 57.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.6 | |||||
| Shareholder Yield % | -1.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -186.91 | |||||
| Net Margin % | -204.82 | |||||
| FCF Margin % | -182.79 | |||||
| ROE % | -248.48 | |||||
| ROA % | -88.49 | |||||
| ROIC % | -127.87 | |||||
| ROC (Joel Greenblatt) % | -477.85 | |||||
| ROCE % | -96.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.55 | |||||
| PB Ratio | 5.56 | |||||
| Price-to-Tangible-Book | 5 | |||||
| EV-to-EBIT | -2.45 | |||||
| EV-to-EBITDA | -2.57 | |||||
| EV-to-Revenue | 4.61 | |||||
| EV-to-FCF | -2.52 | |||||
| Earnings Yield (Greenblatt) % | -40.82 | |||||
| FCF Yield % | -42.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Filament Health Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 2.429 | ||
| EPS (TTM) (C$) | -0.034 | ||
| Beta | 1.65 | ||
| Volatility % | 209.85 | ||
| 14-Day RSI | 50.08 | ||
| 14-Day ATR (C$) | 0.005259 | ||
| 20-Day SMA (C$) | 0.04975 | ||
| 12-1 Month Momentum % | -37.5 | ||
| 52-Week Range (C$) | 0.035 - 0.25 | ||
| Shares Outstanding (Mil) | 211.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Filament Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Filament Health Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Filament Health Corp Frequently Asked Questions
What is Filament Health Corp(NEOE:FH)'s stock price today?
The current price of NEOE:FH is C$0.05. The 52 week high of NEOE:FH is C$0.25 and 52 week low is C$0.04.
When is next earnings date of Filament Health Corp(NEOE:FH)?
The next earnings date of Filament Health Corp(NEOE:FH) is .
Does Filament Health Corp(NEOE:FH) pay dividends? If so, how much?
Filament Health Corp(NEOE:FH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers